tiprankstipranks
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Pharma Wins NMPA Nod for Clinical Trials of New Cholesterol Drug
Company AnnouncementsHansoh Pharma Wins NMPA Nod for Clinical Trials of New Cholesterol Drug
7d ago
3692
Hansoh Pharmaceutical Schedules Board Meeting to Approve Interim Results and Dividend
PremiumCompany Announcements
Hansoh Pharmaceutical Schedules Board Meeting to Approve Interim Results and Dividend
9d ago
3692
Hansoh’s Osteosarcoma Drug HS-20093 Hits Phase III Target, China Filing Planned
PremiumCompany Announcements
Hansoh’s Osteosarcoma Drug HS-20093 Hits Phase III Target, China Filing Planned
16d ago
3692
Why Is Penny Stock NextCure (NXTC) Up Today?
PremiumMarket News
Why Is Penny Stock NextCure (NXTC) Up Today?
30d ago
NXTC
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
PremiumCompany Announcements
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
30d ago
3692
Hansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
PremiumCompany AnnouncementsHansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
1M ago
3692
Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection
Premium
Company Announcements
Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection
1M ago
3692
Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
Premium
Company Announcements
Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
2M ago
3692
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
2M ago
3692
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
PremiumCompany Announcements
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
2M ago
3692
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
PremiumCompany Announcements
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
2M ago
3692
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
PremiumCompany Announcements
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
2M ago
3692
Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
PremiumCompany AnnouncementsHansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
3M ago
3692
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
Premium
Company Announcements
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
3M ago
3692
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
Premium
Company Announcements
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
3M ago
3692
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
PremiumCompany Announcements
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
3M ago
3692
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
PremiumCompany Announcements
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
3M ago
3692
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
PremiumCompany Announcements
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
4M ago
3692
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
PremiumCompany Announcements
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
4M ago
3692
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
PremiumCompany AnnouncementsHansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
4M ago
3692
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
Premium
Company Announcements
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
4M ago
3692
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
Premium
Company Announcements
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
4M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >